Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis halts development of antibiotic drug To take $235 million charge to third-quarter results
Novartis halts development of antibiotic drug To take $235 million charge to third-quarter results
Novartis halts development of antibiotic drug To take $235 million charge to third-quarter results
Submitted by
admin
on August 29, 2008 - 6:34am
Source:
Marketwatch
Headline:
Novartis halts development of antibiotic drug To take $235 million charge to third-quarter results
Do Not Allow Advertisers to Use My Personal information
